|
A nationwide
survey found that most Alzheimer victims do not seek early help,
with the majority reaching the moderate or severe stages of the
disease before they are diagnosed.
On average,
most wait one year after noticing their first symptoms before
they consult with their doctor, the survery found.
A lack of
awareness about signs and symptoms, detection methods, and treatments
may in part explain the delay, according to the Harris Interactive
poll.
Sixty-seven
percent of respondents were unsure of their ability to distinguish
early signs of Alzheimer's disease from signs of normal aging.
One percent
of respondents over age 60 said they have taken a physician-given
questionnaire to identify Alzheimer's disease, although 10 percent
of people over age 65 have the condition, according to the Alzheimer's
Association.
More than
72 percent of respondents were unaware of treatments that can
delay the onset of Alzheimer's disease.
Nearly half
of the family caregivers who reported a wait of at least six months
between first signs or symptoms and consultation said they would
have consulted a doctor sooner had they known prescription medication
was available to help delay the disease progression.
The poll
was administered to more than 2,000 people age 40 and older and
500 caregivers of patients with Alzheimer's disease.
"Although
much has been done to raise awareness of Alzheimer's disease,
we still have a way to go in educating people about how vital
it is to detect the disease in the early stages," said Dr. Steven
Potkin, Professor of Psychiatry and Director of Clinical Psychiatric
Research at the University of California, Irvine.
"People need
to know what to look for and how to take action if they notice
signs. It is crucial to diagnose Alzheimer's disease early because
there are treatments available that can help slow the worsening
of the disease symptoms," he said.
In response
to the survey's results, Novartis Pharmaceuticals, the National
Family Caregivers Association (NFCA) and ABC Television soap star
Linda Dano are joining forces to launch a new educational initiative
called "ID.A.D." (Identify Alzheimer's Disease).
"My dad suffered
with Alzheimer's disease for years, but we didn't know what it
was until he was in the severe stages of the illness," said
Dano. "I want people to learn from my experience and get
information so that this disease can be identified earlier and
patients and family caregivers can get the help they need."
Free IDA.D.
resource kits are available by calling toll-free 1-877-439-3566
or at www.nfcacares.org.
Other
sources: Novartis
|